<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Go-CAR T | Next-Gen CAR T-Cell Therapy for Solid Tumors</title>
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Montserrat:wght@400;700&family=Playfair+Display:wght@700&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css">
    <style>
        :root {
            --primary: #654173;
            --secondary: #f8be1d;
            --light: #f9f5fa;
            --dark: #1a1a1a;
        }
        
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }
        
        body {
            font-family: 'Montserrat', sans-serif;
            color: var(--dark);
            line-height: 1.6;
            background-color: var(--light);
        }
        
        h1, h2, h3, h4 {
            font-family: 'Playfair Display', serif;
            color: var(--primary);
            margin-bottom: 1rem;
        }

        .logo-t {
            font-family: 'Montserrat', sans-serif;
            font-weight: 700;
            color: var(--secondary);
        }
        
        /* Memphis style elements */
        .memphis-box {
            border: 3px solid var(--primary);
            position: relative;
            padding: 2rem;
            margin: 2rem 0;
            background-color: white;
        }
        
        .memphis-box::before {
            content: "";
            position: absolute;
            top: -15px;
            left: -15px;
            right: 15px;
            bottom: 15px;
            border: 3px solid var(--secondary);
            z-index: -1;
        }
        
        .memphis-circle {
            width: 60px;
            height: 60px;
            border-radius: 50%;
            background-color: var(--secondary);
            position: absolute;
            top: -30px;
            right: -30px;
            display: flex;
            align-items: center;
            justify-content: center;
            color: white;
            font-weight: bold;
            font-size: 1.5rem;
        }
        
        .memphis-stripe {
            height: 10px;
            background: repeating-linear-gradient(
                45deg,
                var(--primary),
                var(--primary) 10px,
                var(--secondary) 10px,
                var(--secondary) 20px
            );
            margin: 1.5rem 0;
        }
        
        /* Header styles */
        header {
            background-color: var(--primary);
            color: white;
            padding: 2rem 0;
            text-align: center;
        }
        
        .logo {
            font-size: 2.5rem;
            font-weight: bold;
            margin-bottom: 1rem;
        }
        
        .tagline {
            font-size: 1.5rem;
            margin-bottom: 2rem;
        }
        
        .cta-button {
            display: inline-block;
            background-color: var(--secondary);
            color: var(--primary);
            padding: 0.8rem 2rem;
            text-decoration: none;
            font-weight: bold;
            border-radius: 30px;
            transition: all 0.3s ease;
            border: 2px solid var(--secondary);
        }
        
        .cta-button:hover {
            background-color: transparent;
            color: var(--secondary);
        }
        
        /* Navigation */
        nav {
            background-color: white;
            padding: 1rem 0;
            box-shadow: 0 2px 10px rgba(0,0,0,0.1);
        }
        
        nav ul {
            display: flex;
            justify-content: center;
            list-style: none;
        }
        
        nav ul li {
            margin: 0 1.5rem;
        }
        
        nav ul li a {
            text-decoration: none;
            color: var(--primary);
            font-weight: bold;
            padding: 0.5rem 1rem;
            border-radius: 20px;
            transition: all 0.3s ease;
        }
        
        nav ul li a:hover {
            background-color: var(--primary);
            color: white;
        }
        
        /* Main content */
        .container {
            max-width: 1200px;
            margin: 0 auto;
            padding: 0 2rem;
        }
        
        section {
            padding: 3rem 0;
        }
        
        /* About section */
        .about-content {
            display: grid;
            grid-template-columns: 1fr 1fr;
            gap: 2rem;
        }
        
        .challenges-list {
            list-style-type: none;
        }
        
        .challenges-list li {
            margin-bottom: 1.5rem;
            padding-left: 1.5rem;
            position: relative;
        }
        
        .challenges-list li::before {
            content: "•";
            color: var(--secondary);
            font-size: 2rem;
            position: absolute;
            left: -0.5rem;
            top: -0.7rem;
        }
        
        /* Technology section */
        .tech-features {
            display: grid;
            grid-template-columns: 1fr 1fr;
            gap: 2rem;
            margin-top: 2rem;
        }
        
        .tech-feature {
            background-color: white;
            padding: 2rem;
            border-radius: 10px;
            box-shadow: 0 5px 15px rgba(0,0,0,0.05);
        }
        
        .tech-feature h3 {
            color: var(--secondary);
        }

        .future-tech {
            opacity: 0.7;
            position: relative;
        }
        .future-tech::after {
            content: "(Future Pipeline)";
            position: absolute;
            top: 10px;
            right: 10px;
            font-size: 0.8rem;
            color: var(--secondary);
        }
        
        /* Team section */
        .team-members {
            display: grid;
            grid-template-columns: 1fr 1fr;
            gap: 2rem;
        }
        
        .team-member {
            background-color: white;
            padding: 2rem;
            border-radius: 10px;
            box-shadow: 0 5px 15px rgba(0,0,0,0.05);
            position: relative;
        }
        
        .team-member h3 {
            color: var(--primary);
            margin-bottom: 0.5rem;
        }
        
        .team-member .position {
            color: var(--secondary);
            font-weight: bold;
            margin-bottom: 1rem;
        }

        .team-photo {
            width: 150px;
            height: 150px;
            border-radius: 50%;
            object-fit: cover;
            border: 3px solid var(--secondary);
            margin: 0 auto 1rem;
            display: block;
        }
        
        /* Footer */
        footer {
            background-color: var(--primary);
            color: white;
            padding: 3rem 0;
            text-align: center;
        }
        
        .footer-logo {
            font-size: 2rem;
            margin-bottom: 1.5rem;
        }
        
        .footer-tagline {
            margin-bottom: 2rem;
            max-width: 600px;
            margin-left: auto;
            margin-right: auto;
        }
        
        .contact-button {
            display: inline-block;
            background-color: var(--secondary);
            color: var(--primary);
            padding: 0.8rem 2rem;
            text-decoration: none;
            font-weight: bold;
            border-radius: 30px;
            transition: all 0.3s ease;
            margin-top: 1rem;
            border: 2px solid var(--secondary);
        }
        
        .contact-button:hover {
            background-color: transparent;
            color: var(--secondary);
        }

        /* Mobile Responsiveness */
        @media (max-width: 768px) {
            nav ul {
                flex-direction: column;
                text-align: center;
            }
            
            .team-members, .tech-features {
                grid-template-columns: 1fr;
            }
            
            .memphis-circle {
                width: 40px;
                height: 40px;
                top: -20px;
                right: -20px;
                font-size: 1rem;
            }
            
            .container {
                padding: 0 1rem;
            }

            .logo {
                font-size: 2rem;
            }

            .tagline {
                font-size: 1.2rem;
            }

            .team-photo {
                width: 120px;
                height: 120px;
            }
        }
    </style>
</head>
<body>
    <header>
        <div class="container">
            <div class="logo">Go-CAR<span class="logo-t">T</span></div>
            <div class="tagline">Next-Gen CAR T-Cell Therapy for Solid Tumors</div>
            <a href="#join" class="cta-button">Join Our Mission</a>
        </div>
    </header>
    
    <nav>
        <ul>
            <li><a href="#about">About</a></li>
            <li><a href="#technology">Technology</a></li>
            <li><a href="#desci">DeSci</a></li>
            <li><a href="#team">Our Team</a></li>
            <li><a href="#contact">Contact</a></li>
        </ul>
    </nav>
    
    <main class="container">
        <section id="about">
            <div class="memphis-box">
                <div class="memphis-circle">1</div>
                <h2>About</h2>
                <p>CAR T-cells have revolutionized cancer treatment through their precise targeting capabilities. While impactful, current implementations require crucial improvements to maximize safety and efficacy.</p>
                <p>Key challenges of existing CAR T-Cell Therapies:</p>
                <ul class="challenges-list">
                    <li><strong>On-Target, Off-Tumor Toxicity</strong><br>CAR T-cells may attack healthy tissues expressing similar antigens, creating safety risks.</li>
                    <li><strong>Tumor Antigen Escape</strong><br>Tumors can mutate target antigens, evading immune detection.</li>
                    <li><strong>High Cost and Complex Manufacturing</strong><br>Personalized production remains expensive and difficult to scale.</li>
                    <li><strong>Loss of Therapeutic Efficacy</strong><br>T-cell exhaustion limits long-term effectiveness.</li>
                </ul>
            </div>
        </section>
        
        <div class="memphis-stripe"></div>
        
        <section id="technology">
            <div class="memphis-box">
                <div class="memphis-circle">2</div>
                <h2>Our Technology</h2>
                <div class="tech-features">
                    <div class="tech-feature">
                        <h3>AND-Gate Logic (Current Focus)</h3>
                        <img src="and-gate-sketch.png" alt="Dual antigen activation system" style="max-width: 100%; margin: 1rem 0; border: 2px solid var(--primary);">
                        <p>Our proprietary dual-antigen verification system requires simultaneous recognition of two tumor-specific markers through synthetic receptor pairs. This significantly reduces off-target effects while maintaining anti-tumor potency.</p>
                    </div>
                    <div class="tech-feature future-tech">
                        <h3>Hypoxia Switch</h3>
                        <p>Future development: Oxygen-responsive genetic circuit activating therapeutic functions exclusively in hypoxic tumor environments.</p>
                    </div>
                </div>
            </div>
        </section>
        
        <div class="memphis-stripe"></div>
        
        <section id="desci">
            <div class="memphis-box">
                <div class="memphis-circle">3</div>
                <h2>What is DeSci?</h2>
                <p>DeSci implements token-based governance over intellectual property through legally-binding Sponsored Research Agreements (SRAs). Our framework features:</p>
                <ul class="challenges-list">
                    <li>IP ownership governed by token holders</li>
                    <li>Transparent research accounting via smart contracts</li>
                    <li>Community-driven resource allocation</li>
                </ul>
                
                <h3>How Go-CAR T Uses DeSci</h3>
                <div class="tech-features">
                    <div class="tech-feature">
                        <h3>Token-Based Funding</h3>
                        <p>We're pioneering IP-NFTs to democratize biotech investment while aligning stakeholder incentives through transparent, blockchain-based agreements.</p>
                    </div>
                    <div class="tech-feature">
                        <h3>Open Science Collaboration</h3>
                        <p>All non-sensitive research data is accessible through decentralized storage platforms, enabling global collaboration.</p>
                    </div>
                </div>
            </div>
        </section>
        
        <div class="memphis-stripe"></div>
        
        <section id="team">
            <div class="memphis-box">
                <div class="memphis-circle">4</div>
                <h2>Our Team</h2>
                <div class="team-members">
                    <div class="team-member">
                        <img src="pictures/henry.JPG" alt="Henry Erdlei" class="team-photo">
                        <h3>Henry Erdlei</h3>
                        <div class="position">Chief Executive Officer (CEO)</div>
                        <p>Henry conducted doctoral research in translational tumour immunology at the Max Delbrück Center for Molecular Medicine, following his medical training at Charité – Universitätsmedizin Berlin. His work focuses on bridging fundamental immunology discoveries with clinical applications for solid tumor therapies.</p>
                    </div>
                    <div class="team-member">
                        <img src="pictures/aray.JPG" alt="Araliym Myrzagaliyeva" class="team-photo">
                        <h3>Araliym Myrzagaliyeva</h3>
                        <div class="position">Chief Technology Officer (CTO)</div>
                        <p>Arailym oversees technological development with experience spanning synthetic biology and global health advocacy. As Founder of the Breast Cancer Awareness Foundation in Kazakhstan and former Product Director at NanoX, she brings unique perspective to therapeutic development.</p>
                    </div>
                    <div class="team-member">
                        <img src="pictures/chase.JPG" alt="Chase Blakeley" class="team-photo">
                        <h3>Chase Blakeley</h3>
                        <div class="position">Chief Operations Officer (COO)</div>
                        <p>Chase manages project coordination, IP-NFT strategy, and community engagement. With 4+ years in high-tech business development at StoryBuilt and Oracle, he combines analytical rigor with operational excellence. Chase holds a B.S. in Economics from Southern Methodist University and is passionate about advancing decentralized biotech innovation.</p>
                    </div>
                </div>
            </div>
        </section>
    </main>
    
    <footer id="contact">
        <div class="container">
            <div class="footer-logo">Go-CAR<span class="logo-t">T</span></div>
            <div class="footer-tagline">Building the future of cancer therapy through decentralized innovation</div>
            
            <div style="margin: 2rem 0;">
                <a href="[LINKEDIN_URL]" target="_blank" style="color: white; margin: 0 1rem;">
                    <i class="fab fa-linkedin fa-2x"></i>
                </a>
                <a href="[TWITTER_URL]" target="_blank" style="color: white; margin: 0 1rem;">
                    <i class="fab fa-x-twitter fa-2x"></i>
                </a>
            </div>

            <a href="mailto:contact@gocart.com" class="contact-button">Contact Us</a>
            
            <p style="font-size: 0.9rem; margin-top: 2rem;">
                Token governance details and trading platforms will be announced following regulatory approvals.
            </p>
        </div>
    </footer>
</body>
</html>
